*If you know of a trainee or early-career physician-scientist, who will benefit from the information below, please
feel free to forward them this email.*
Hello Everyone,
We hope this email finds you well!
We are excited to share that the DiabDocs program
is now soliciting a fourth cycle of letters of intent for applications for our mentored career development program from early career physician scientists engaged in research relevant to diabetes and
within the scope of NIDDK including basic, translational, clinical, epidemiology/biostatistical, informatics, health services or health policy projects. Most funded scholars will focus on type 1 diabetes (T1D) research, and limited slots are
available for persons working in type 2 diabetes (T2D).
The letters of intent (LOIs) are due on Tuesday, November 12, 2024, at 5pm (ET) via the REDCap
form: https://redcap.link/x7upmzv7
After reviewing the LOIs, individuals will be invited to submit full applications
by Monday, January 13, 2025, at 5pm (ET) and an in-person program retreat in Baltimore, MD between March 5-6,
2025, that will include interviews. Award funding will begin on July 1, 2025. Please feel free to distribute the LOI Announcement to your contacts and let us know where you
have disseminated the information.
In addition, please find attached the eligibility criteria for program scholars for your review and records. The verbiage
comes from the NIH funding opportunity announcement (FOA) statement.
Resubmission Guidelines:
-
For applicants resubmitting their proposal, a LOI must be received by November
12, 2024, to show interest in the program.
-
LOI must include: 1) the original AIMS/Research Plan pages from the original full application and 2) a revised AIMS/Research
Plan page demonstrating how the applicant intends to improve the proposal.
-
In addition, if invited to submit a full application, applicants must submit a 1-page response to the comments/feedback
received from the study section in the previous recruitment cycle. The 1-page response would be required at the full application stage and not the LOI stage.
